The regional sector for peptide-based substances is experiencing significant development, driven by rising demand in therapeutic applications, mainly in cosmetics and nutraceutical fields. Current developments point a change towards tailored medicine and regenerative treatments, generating promising possibilities for firms participating in peptidic